The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1139
September 16, 2002
View Complete Issue         Table of Contents 2019 
Is Accutane really dangerous?
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Is Accutane really dangerous?
September 16, 2002 (Issue: 1139)
Isotretinoin (Accutane - Roche), an effective oral drug for treatment of acne, will soon be available generically. Concerns about its adverse effects, particularly psychiatric symptoms in adolescents, have been widely reported in the media.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Is Accutane really dangerous?
Article code: 1139c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.